Inspire Medical Systems Stock-Based Compensation 2017-2024 | INSP

Inspire Medical Systems annual/quarterly stock-based compensation history and growth rate from 2017 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
  • Inspire Medical Systems stock-based compensation for the quarter ending December 31, 2024 was $0.116B, a 40.67% increase year-over-year.
  • Inspire Medical Systems stock-based compensation for the twelve months ending December 31, 2024 was $0.288B, a 43.84% increase year-over-year.
  • Inspire Medical Systems annual stock-based compensation for 2024 was $0.116B, a 40.67% increase from 2023.
  • Inspire Medical Systems annual stock-based compensation for 2023 was $0.082B, a 58.69% increase from 2022.
  • Inspire Medical Systems annual stock-based compensation for 2022 was $0.052B, a 98.53% increase from 2021.
Inspire Medical Systems Annual Stock-Based Compensation
(Millions of US $)
2024 $116
2023 $82
2022 $52
2021 $26
2020 $13
2019 $6
2018 $1
2017 $0
2016 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.303B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.209B 54.83
Hims & Hers Health (HIMS) United States $15.018B 381.89
Tempus AI (TEM) United States $13.495B 0.00
IRhythm Technologies (IRTC) United States $3.538B 0.00
Privia Health (PRVA) United States $3.060B 255.00
Enovis (ENOV) United States $2.533B 16.87
Clover Health Investments (CLOV) United States $2.280B 0.00
Azenta (AZTA) United States $2.075B 96.64
Schrodinger (SDGR) United States $1.895B 0.00
Omnicell (OMCL) United States $1.858B 40.53
Phreesia (PHR) United States $1.725B 0.00
10x Genomics (TXG) United States $1.465B 0.00
Butterfly Network (BFLY) United States $1.004B 0.00
Talkspace (TALK) United States $0.652B 0.00
Fulgent Genetics (FLGT) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.517B 0.00
TruBridge (TBRG) United States $0.426B 124.04
Nyxoah SA (NYXH) Belgium $0.357B 0.00
Health Catalyst (HCAT) United States $0.338B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.319B 0.00
Pulmonx (LUNG) United States $0.262B 0.00
American Well (AMWL) United States $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
111 (YI) China $0.069B 0.00
CareCloud (CCLD) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Outset Medical (OM) United States $0.050B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.028B 0.00
MSP Recovery (MSPR) United States $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Tivic Health Systems (TIVC) United States $0.005B 0.00
Syra Health (SYRA) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00